{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:33:25Z","timestamp":1792276405113,"version":"4.4.0"},"reference-count":153,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/qco.0b013e32833bcc8a","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T05:51:27Z","timestamp":1277877087000},"page":"346-358","source":"Crossref","is-referenced-by-count":93,"title":["Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges"],"prefix":"10.1097","volume":"23","author":[{"given":"Winfried V","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1469-0691.2008.01965.x","article-title":"Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991\u20132005","volume":"14","author":"Allard","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/589717","article-title":"Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000\u20132006","volume":"198","author":"Laupland","year":"2008","journal-title":"J Infect Dis"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1086\/648442","article-title":"Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study","volume":"49","author":"El Atrouni","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R4-10-20210211","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/323459","article-title":"Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998","volume":"184","author":"Morin","year":"2001","journal-title":"J Infect Dis"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"Benfield","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"R6-10-20210211","first-page":"S593","article-title":"Incidence and mortality of Staphylococcus aureus bacteraemia in Iceland. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P1996]","volume":"16","author":"Asgeirsson","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/jhin.2002.1274","article-title":"MRSA bacteraemia: North\/South study of MRSA in Ireland 1999","volume":"52","author":"McDonald","year":"2002","journal-title":"J Hosp Infect"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/00365540600810026","article-title":"The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden","volume":"39","author":"Jacobsson","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3201\/eid1111.050524","article-title":"Staphylococcus aureus bacteremia, Europe","volume":"11","author":"Tiemersma","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3201\/eid1104.040772","article-title":"Staphylococcus aureus bacteremia, Australia","volume":"11","author":"Collignon","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1444-0903.2001.00029.x","article-title":"Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality","volume":"31","author":"Hill","year":"2001","journal-title":"Intern Med J"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1445-5994.2009.01910.x","article-title":"Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand.","volume":"40","author":"Huggan","year":"2009","journal-title":"Intern Med J"},{"key":"R13-10-20210211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(09)70022-2","article-title":"Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia","volume":"9","author":"Nickerson","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R14-10-20210211","doi-asserted-by":"crossref","first-page":"e4308","DOI":"10.1371\/journal.pone.0004308","article-title":"Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance","volume":"4","author":"Nickerson","year":"2009","journal-title":"PLoS One"},{"key":"R15-10-20210211","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3855\/jidc.413","article-title":"Invasive bacteria isolates from children with severe infections in a Nigerian hospital","volume":"3","author":"Onipede","year":"2009","journal-title":"J Infect Dev Ctries"},{"key":"R16-10-20210211","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/599003","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in Gaborone, Botswana","volume":"30","author":"Wood","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1086\/597521","article-title":"Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome","volume":"30","author":"Burke","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R18-10-20210211","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jp.2009.119","article-title":"The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000\u20132007","volume":"30","author":"Carey","year":"2010","journal-title":"J Perinatol"},{"key":"R19-10-20210211","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.inf.0000261112.53035.4c","article-title":"Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000","volume":"26","author":"Frederiksen","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R20-10-20210211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1099\/jmm.0.015271-0","article-title":"The changing aetiology of paediatric bacteraemia in England and Wales, 1998\u20132007","volume":"59","author":"Henderson","year":"2010","journal-title":"J Med Microbiol"},{"key":"R21-10-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/INF.0b013e318187a87d","article-title":"Community-acquired bacteremia among children admitted to a rural hospital in Mozambique","volume":"28","author":"Siga\u00faque","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R22-10-20210211","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1086\/605473","article-title":"Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study","volume":"200","author":"Darmstadt","year":"2009","journal-title":"J Infect Dis"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"e1000215","DOI":"10.1371\/journal.pmed.1000215","article-title":"Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis","volume":"7","author":"Grundmann","year":"2010","journal-title":"PLoS Med"},{"key":"R24-10-20210211","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/j.1326-5377.2009.tb02841.x","article-title":"Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand","volume":"191","author":"Turnidge","year":"2009","journal-title":"Med J Aust"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjmed.2008.09.040","article-title":"Staphylococcus aureus bacteremia among patients with healthcare-associated fever","volume":"122","author":"Stryjewski","year":"2009","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"R26-10-20210211","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1086\/598187","article-title":"Patients at risk of complications of Staphylococcus aureus bloodstream infection","volume":"48","author":"del Rio","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R27-10-20210211","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.2009.153","article-title":"Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997\u20132007","volume":"301","author":"Burton","year":"2009","journal-title":"JAMA"},{"key":"R28-10-20210211","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5694\/j.1326-5377.2009.tb02847.x","article-title":"Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control","volume":"191","author":"Dendle","year":"2009","journal-title":"Med J Aust"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa0808939","article-title":"Preventing surgical-site infections in nasal carriers of Staphylococcus aureus","volume":"362","author":"Bode","year":"2010","journal-title":"N Engl J Med"},{"key":"R30-10-20210211","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1469-0691.2009.02717.x","article-title":"Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococcus aureus in Spain","volume":"15","author":"Rodr\u00edguez-Ba\u00f1o","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R31-10-20210211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/593953","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea","volume":"30","author":"Park","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl. 2","key":"R32-10-20210211","first-page":"S594","article-title":"The clinical feature and mortality of community-associated methicillin resistance Staphylococcus aureus: comparison with healthcare-associated methicillin-resistant and methicillin-susceptible S. aureus bacteraemia. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P1999]","volume":"16","author":"Kang","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R33-10-20210211","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10096-008-0632-1","article-title":"Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review","volume":"28","author":"Robinson","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R34-10-20210211","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/527389","article-title":"Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus","volume":"46","author":"Wang","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R35-10-20210211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-9-112","article-title":"Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois","volume":"9","author":"Mongkolrattanothai","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R36-10-20210211","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1086\/651313","article-title":"Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995\u20132007","volume":"31","author":"Simor","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R37-10-20210211","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOP.0b013e328339421b","article-title":"Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.","volume":"22","author":"Odell","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R38-10-20210211","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(09)61999-1","article-title":"Community-associated meticillin-resistant Staphylococcus aureus.","volume":"375","author":"DeLeo","year":"2010","journal-title":"Lancet"},{"key":"R39-10-20210211","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/595963","article-title":"Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals","volume":"30","author":"Jenkins","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R40-10-20210211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijantimicag.2009.03.004","article-title":"Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections","volume":"34","author":"Moore","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R41-10-20210211","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/JCM.01949-09","article-title":"Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin","volume":"48","author":"Welsh","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R42-10-20210211","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3201\/eid1604.090107","article-title":"Community-associated methicillin-resistant Staphylococcus aureus strains in pediatric intensive care unit","volume":"16","author":"Milstone","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R43-10-20210211","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/INF.0b013e31819988bf","article-title":"Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995\u20132004","volume":"28","author":"Lessa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R44-10-20210211","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/593954","article-title":"Differences between \u2018classical\u2019 risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain","volume":"30","author":"Vidal","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R45-10-20210211","first-page":"568","article-title":"Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management","volume":"20","author":"Lewis","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R46-10-20210211","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QCO.0b013e328331fbcd","article-title":"Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of antiGram-positive antibiotics","volume":"22","author":"Chua","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R47-10-20210211","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R48-10-20210211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R49-10-20210211","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1345\/aph.1M526","article-title":"Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.","volume":"44","author":"Rong","year":"2010","journal-title":"Ann Pharmacother"},{"key":"R50-10-20210211","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jac\/dkp319","article-title":"Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals","volume":"64","author":"Sader","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R51-10-20210211","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkq009","article-title":"Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK","volume":"65","author":"Kirby","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R52-10-20210211","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/AAC.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R53-10-20210211","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.01316-09","article-title":"Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995\u20132006","volume":"54","author":"Adam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R54-10-20210211","first-page":"637","article-title":"Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006","volume":"20","author":"Chung","year":"2010","journal-title":"J Microbiol Biotechnol"},{"key":"R55-10-20210211","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.00407-09","article-title":"Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005","volume":"47","author":"Mason","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R56-10-20210211","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA","volume":"53","author":"Horne","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R57-10-20210211","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis"},{"key":"R58-10-20210211","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jinf.2009.11.011","article-title":"Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong","volume":"60","author":"Ho","year":"2010","journal-title":"J Infect"},{"key":"R59-10-20210211","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/AAC.00307-09","article-title":"Correlation between vancomycin MIC values and those of other agents against Gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus","volume":"53","author":"Patel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R60-10-20210211","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/605636","article-title":"Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus","volume":"49","author":"Pillai","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R61-10-20210211","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10096-008-0692-2","article-title":"Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus mitral valve acute bacterial endocarditis","volume":"28","author":"Cunha","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R62-10-20210211","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2008.12.010","article-title":"Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy","volume":"33","author":"Tenover","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R63-10-20210211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2008.06.028","article-title":"Fatal bacteraemia caused by daptomycin-nonsusceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease","volume":"33","author":"Kuo","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R64-10-20210211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10096-006-0096-0","article-title":"Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia","volume":"25","author":"Khatib","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R65-10-20210211","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MD.0b013e3181b8fccb","article-title":"Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia","volume":"88","author":"Lahey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R66-10-20210211","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/605555","article-title":"Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries","volume":"49","author":"Ammerlaan","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R67-10-20210211","first-page":"S188","article-title":"Staphylococcus aureus bloodstream infection management indicators as quality indicators for hospital antibiotic stewardship: feasibility study by the ABS International Quality Indicators (ABS QI) team. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, May 2009 [abstract #P764]","volume":"15","author":"Kern","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R69-10-20210211","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","author":"Kaech","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R70-10-20210211","doi-asserted-by":"crossref","first-page":"654858","DOI":"10.1155\/2010\/654858","article-title":"Clinical and microbiological determinants of outcome in Staphylococcus aureus bacteraemia.","volume":"2010","author":"Price","year":"2010","journal-title":"Int J Microbiol"},{"issue":"Suppl 2","key":"R72-10-20210211","first-page":"S594","article-title":"Risk factors and attributable mortality in patients with nosocomial methicillin-resistant Staphylococcus aureus bacteraemia. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P1998]","volume":"16","author":"Chen","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R73-10-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhin.2006.09.022","article-title":"Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK","volume":"65","author":"Das","year":"2007","journal-title":"J Hosp Infect"},{"issue":"Suppl 2","key":"R74-10-20210211","first-page":"S593","article-title":"MSSA bloodstream infection, MRSA's evil twin! A review of the epidemiology, risk factors and outcomes among hospitalized patients with Staphylococcus aureus (MSSA & MRSA) bacteraemia. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P1997]","volume":"16","author":"Przybylo","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R75-10-20210211","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinf.2009.07.015","article-title":"Mortality of Staphylococcus aureus bacteremia and infectious diseases specialist consultation: a study of 521 patients in Germany","volume":"59","author":"Rieg","year":"2009","journal-title":"J Infect"},{"issue":"Suppl 2","key":"R76-10-20210211","first-page":"S686","article-title":"Mortality and prognosis factors for MRSA bloodstream infections in the intensive care unit: a retrospective cohort study. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #R2294]","volume":"16","author":"Castillo","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R77-10-20210211","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/archinte.167.17.1861","article-title":"Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes","volume":"167","author":"Hawkins","year":"2007","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"R78-10-20210211","first-page":"S413","article-title":"High burden of S. aureus bloodstream infections in European hospitals, irrespective of methicillin susceptibility. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract P1442]","volume":"16","author":"de Kraker","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R79-10-20210211","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/606163","article-title":"Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss","volume":"30","author":"Herzke","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R80-10-20210211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2008.11.003","article-title":"Impact of inappropriate empirical therapy for sepsis due to healthcare-associated methicillin-resistant Staphylococcus aureus","volume":"58","author":"Rodr\u00edguez-Ba\u00f1o","year":"2009","journal-title":"J Infect"},{"key":"R81-10-20210211","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"key":"R82-10-20210211","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2008.04.011","article-title":"Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an emergency department of a medical centre in Taiwan","volume":"32","author":"Liao","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R83-10-20210211","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R84-10-20210211","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/597359","article-title":"Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin","volume":"48","author":"Price","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R85-10-20210211","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/649572","article-title":"Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?","volume":"201","author":"Lalueza","year":"2010","journal-title":"J Infect Dis"},{"key":"R86-10-20210211","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2215\/CJN.03760708","article-title":"Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients","volume":"4","author":"Li","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R87-10-20210211","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0310057X0903700320","article-title":"Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study","volume":"37","author":"Ho","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"R88-10-20210211","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10096-009-0808-3","article-title":"Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis","volume":"28","author":"Kanafani","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R89-10-20210211","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1532-5415.2009.02666.x","article-title":"Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.","volume":"58","author":"Big","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"R91-10-20210211","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nm.1965","article-title":"Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome","volume":"15","author":"Chau","year":"2009","journal-title":"Nat Med"},{"key":"R92-10-20210211","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes","volume":"9","author":"Lappin","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R93-10-20210211","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2009.08.001","article-title":"Concomitant Staphylococcus aureus bacteriuria is associated with complicated S. aureus bacteremia","volume":"59","author":"Pulcini","year":"2009","journal-title":"J Infect"},{"key":"R94-10-20210211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2009.05.002","article-title":"The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia","volume":"59","author":"Choi","year":"2009","journal-title":"J Infect"},{"key":"R95-10-20210211","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jhm.623","article-title":"Staphylococcus aureus bacteremia with associated S. aureus bacteriuria as a predictor of complications and mortality","volume":"5","author":"Perez-Jorge","year":"2010","journal-title":"J Hosp Med"},{"key":"R96-10-20210211","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","article-title":"Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin","volume":"65","author":"Yoon","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R97-10-20210211","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/00365540802441711","article-title":"Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time","volume":"41","author":"Khatib","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R98-10-20210211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/595738","article-title":"Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model","volume":"199","author":"Xiong","year":"2009","journal-title":"J Infect Dis"},{"key":"R99-10-20210211","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/649429","article-title":"Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes","volume":"201","author":"Moise","year":"2010","journal-title":"J Infect Dis"},{"key":"R100-10-20210211","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/529190","article-title":"Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia","volume":"46","author":"Jenkins","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R101-10-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jinf.2009.03.011","article-title":"Risk factors for recurrence after Staphylococcus aureus bacteraemia: a retrospective matched case-control study","volume":"58","author":"Walker","year":"2009","journal-title":"J Infect"},{"key":"R103-10-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/596731","article-title":"Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?","volume":"30","author":"Ben-David","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R104-10-20210211","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/514686","article-title":"Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients","volume":"27","author":"Fowler","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"R105-10-20210211","first-page":"S66","article-title":"Formal infectious disease consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, May 2009 [abstract #O302]","volume":"15","author":"Robinson","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R106-10-20210211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/43.1.113","article-title":"The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis","volume":"43","author":"Leder","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R107-10-20210211","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.01232-08","article-title":"Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus","volume":"53","author":"Hughes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R108-10-20210211","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1128\/AAC.01410-06","article-title":"Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin","volume":"51","author":"Landersdorfer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R109-10-20210211","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R110-10-20210211","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.01325-09","article-title":"Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.","volume":"54","author":"Nannini","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R111-10-20210211","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2146\/ajhp080629","article-title":"Is vancomycin obsolete?","volume":"66","author":"Legendre","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R112-10-20210211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R113-10-20210211","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults. Summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R114-10-20210211","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0b013e3181906e40","article-title":"Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate","volume":"285","author":"Frymoyer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R115-10-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14740330903413514","article-title":"Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections","volume":"9","author":"Hermsen","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 2","key":"R116-10-20210211","first-page":"S380","article-title":"Cost and outcome implications of the newly developed high-dose vancomycin consensus guidelines. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P1340]","volume":"16","author":"Kullar","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R117-10-20210211","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijantimicag.2009.07.011","article-title":"Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy","volume":"34","author":"Ingram","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R118-10-20210211","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/ALN.0b013e3181a97272","article-title":"Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion","volume":"111","author":"Hutschala","year":"2009","journal-title":"Anesthesiology"},{"key":"R119-10-20210211","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/AAC.01149-08","article-title":"Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients","volume":"53","author":"Pea","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R120-10-20210211","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":"Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections","volume":"34","author":"Berthoin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"R121-10-20210211","first-page":"S595","article-title":"Cotrimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P2003]","volume":"16","author":"Goldberg","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R122-10-20210211","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/dkp456","article-title":"A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists","volume":"65","author":"Hussain","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R123-10-20210211","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CCM.0b013e3181b9ecea","article-title":"Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia","volume":"38","author":"Jung","year":"2010","journal-title":"Crit Care Med"},{"key":"R124-10-20210211","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/605572","article-title":"Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"49","author":"Deresinski","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R125-10-20210211","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"Forrest","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R126-10-20210211","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"R127-10-20210211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jac\/dkp377","article-title":"Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?","volume":"65","author":"Nguyen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R128-10-20210211","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkp346","article-title":"Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies","volume":"64","author":"Steenbergen","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R129-10-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10096-009-0837-y","article-title":"Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection","volume":"29","author":"Ferry","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R130-10-20210211","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R131-10-20210211","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00208-09","article-title":"Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus","volume":"53","author":"Murillo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R132-10-20210211","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/AAC.00775-08","article-title":"Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection","volume":"53","author":"Baldoni","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R133-10-20210211","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.00047-09","article-title":"Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin","volume":"53","author":"John","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R134-10-20210211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/dkn513","article-title":"Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus","volume":"63","author":"Rose","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R135-10-20210211","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.00051-09","article-title":"Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"53","author":"Mir\u00f3","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R136-10-20210211","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/AAC.00134-09","article-title":"Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R137-10-20210211","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"R138-10-20210211","first-page":"S597","article-title":"Transoesophageal echocardiography in Staphylococcus aureus bacteraemia: when is it dispensable? 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 2010 [abstract #P2006]","volume":"16","author":"Kaasch","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R139-10-20210211","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"R140-10-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2334-10-17","article-title":"Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort","volume":"10","author":"G\u00e1lvez-Acebal","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R141-10-20210211","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.109.877365","article-title":"Age-dependent profile of left-sided infective endocarditis: a 3-center experience","volume":"121","author":"L\u00f3pez","year":"2010","journal-title":"Circulation"},{"key":"R143-10-20210211","doi-asserted-by":"crossref","first-page":"586","DOI":"10.7326\/0003-4819-150-9-200905050-00004","article-title":"Healthcare-associated native valve endocarditis: importance of nonnosocomial acquisition","volume":"150","author":"Benito","year":"2009","journal-title":"Ann Intern Med"},{"key":"R144-10-20210211","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1002\/clc.20498","article-title":"Endocarditis complicating central venous catheter bloodstream infections: a unique form of healthcare associated endocarditis","volume":"32","author":"Chrissoheris","year":"2009","journal-title":"Clin Cardiol"},{"key":"R145-10-20210211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1540-8159.2009.02565.x","article-title":"Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.","volume":"33","author":"Uslan","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"R146-10-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e318194da65","article-title":"Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome","volume":"88","author":"Fern\u00e1ndez Guerrero","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R147-10-20210211","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hlc.2008.10.016","article-title":"Methicillin resistant Staphylococcus aureus endocarditis in an Australian tertiary hospital: 1991\u20132006","volume":"18","author":"Rogers","year":"2009","journal-title":"Heart Lung Circ"},{"key":"R148-10-20210211","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.108.834432","article-title":"Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study","volume":"120","author":"Cooper","year":"2009","journal-title":"Circulation"},{"key":"R149-10-20210211","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00109-010-0630-5","article-title":"Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid.","volume":"88","author":"Sheen","year":"2010","journal-title":"J Mol Med"},{"key":"R150-10-20210211","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000235579","article-title":"Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe?","volume":"114","author":"Rasmussen","year":"2009","journal-title":"Cardiology"},{"key":"R151-10-20210211","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jinf.2009.03.006","article-title":"Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid","volume":"58","author":"Eisen","year":"2009","journal-title":"J Infect"},{"key":"R152-10-20210211","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R153-10-20210211","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1099\/jmm.0.006486-0","article-title":"In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis","volume":"58","author":"Kirby","year":"2009","journal-title":"J Med Microbiol"},{"key":"R154-10-20210211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2009.08.019","article-title":"High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides","volume":"35","author":"Lichterfeld","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R155-10-20210211","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1345\/aph.1M085","article-title":"Safety and clinical outcomes when utilizing high-dose (> or =8 mg\/kg) daptomycin therapy","volume":"43","author":"Moise","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R156-10-20210211","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.01307-08","article-title":"Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis","volume":"53","author":"Chambers","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R157-10-20210211","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ahj.2008.06.031","article-title":"The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis","volume":"156","author":"Tleyjeh","year":"2008","journal-title":"Am Heart J"},{"key":"R158-10-20210211","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.109.864488","article-title":"Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias","volume":"121","author":"Lalani","year":"2010","journal-title":"Circulation"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0b013e32833bcc8a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:25Z","timestamp":1786040605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001432-201008000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e32833bcc8a","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}